KLIK-GHK 100mg

KLIK-GHK 100mg is based on research involving GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex), a naturally occurring copper-binding tripeptide first identified in human plasma in the early 1970s. GHK is composed of the amino acids glycine, histidine and lysine, and readily binds copper (Cu²⁺), forming the biologically active complex known as GHK-Cu. Interest in GHK-Cu has grown due to its apparent role in regulating tissue remodelling, extracellular matrix maintenance, wound repair and skin physiology. Laboratory research suggests the peptide may influence the expression of numerous genes involved in collagen production, inflammatory regulation, antioxidant defence and cellular regeneration. Unlike growth factors that activate a single receptor pathway, GHK-Cu appears to function as a gene-modulating signalling peptide, influencing multiple biological processes associated with tissue maintenance and repair. Research spans dermatology, cosmetic science, wound healing, connective tissue biology, hair follicle research and regenerative medicine. While many laboratory findings are encouraging, clinical evidence varies depending on the specific application being studied.

GHK is produced naturally within the human body and can be detected in blood plasma, saliva and urine. Concentrations decline gradually with age, leading researchers to investigate whether reduced GHK availability contributes to age-related changes in tissue repair and extracellular matrix integrity. Copper is an essential trace element required for numerous biological processes including: • Collagen cross-linking • Elastin formation • Antioxidant enzyme activity • Energy metabolism • Connective tissue maintenance By binding copper, GHK-Cu serves as a transport and signalling molecule capable of influencing multiple cellular pathways. MOLECULAR STRUCTURE GHK-Cu consists of glycine, histidine, lysine and one copper ion (Cu²⁺). The histidine residue provides a high-affinity binding site for copper, allowing stable complex formation under physiological conditions. Researchers believe copper delivery is only one aspect of GHK-Cu biology, with much of its activity resulting from modulation of gene expression and cellular signalling.

Current evidence suggests GHK-Cu influences several interconnected biological pathways. Areas under investigation include collagen synthesis, extracellular matrix remodelling, growth factor regulation, anti-inflammatory signalling, antioxidant defence, stem cell biology and cellular migration. Rather than functioning through a single receptor, GHK-Cu appears to coordinate multiple repair-related processes simultaneously. COLLAGEN AND EXTRACELLULAR MATRIX One of the best-characterised actions of GHK-Cu involves regulation of the extracellular matrix (ECM). The ECM provides structural support for tissues and consists primarily of collagen, elastin, glycosaminoglycans, fibronectin and proteoglycans. Laboratory studies suggest GHK-Cu may influence: • Type I collagen synthesis • Type III collagen synthesis • Elastin production • Fibroblast activity • Matrix remodelling Researchers have also investigated its interaction with matrix metalloproteinases (MMPs), enzymes responsible for controlled breakdown and rebuilding of connective tissue. ANTI-INFLAMMATORY AND ANTIOXIDANT SIGNALLING Experimental investigations have explored effects on cytokine expression, oxidative stress, reactive oxygen species and tissue remodelling. These mechanisms may contribute indirectly to observed changes in wound repair within laboratory models.

WOUND HEALING RESEARCH Wound healing represents one of the most extensively studied areas of GHK-Cu research. Experimental investigations have examined skin injury, surgical wounds, chronic wounds, burns and diabetic wound models. Reported laboratory findings include increased fibroblast migration, enhanced collagen deposition, improved angiogenesis, accelerated re-epithelialisation and organised extracellular matrix formation. Several clinical dermatology studies have also evaluated topical GHK-Cu preparations for skin repair. SKIN BIOLOGY Ageing skin undergoes progressive structural changes involving reduced collagen content, elastin fragmentation, decreased hydration, slower wound healing and altered extracellular matrix organisation. Researchers have investigated GHK-Cu for its potential influence on skin elasticity, dermal thickness, fine lines, photodamage and barrier function. Although cosmetic studies report encouraging findings, improvements vary between investigations and depend upon formulation, treatment duration and study design. HAIR FOLLICLE RESEARCH Experimental studies suggest possible effects involving hair follicle size, dermal papilla cells, follicular vascularisation, growth factor expression and hair cycling. Researchers have proposed that improved extracellular matrix organisation and angiogenesis may contribute to follicle health. Current human evidence remains relatively limited compared with approved pharmacological treatments for hair loss. GENE EXPRESSION RESEARCH Laboratory studies suggest the peptide may regulate hundreds of genes associated with tissue repair, inflammation, oxidative stress, cellular defence, protein turnover and stem cell activity. Although these observations have generated significant scientific interest, further research is required to determine their physiological significance in humans. HUMAN CLINICAL EVIDENCE Human research involving GHK-Cu has primarily focused on dermatological applications — photoaged skin, fine wrinkles, skin texture, wound healing and cosmetic formulations. Several studies have demonstrated improvements in selected skin parameters following topical administration. However, evidence supporting systemic administration remains limited, and many mechanistic observations continue to originate from laboratory research.

Current pharmacokinetic knowledge remains incomplete. Areas requiring additional investigation include: • Tissue distribution • Cellular uptake • Metabolism • Biological half-life • Systemic bioavailability Most published human studies involve topical formulations rather than systemic administration.

SAFETY PROFILE GHK is an endogenous peptide naturally present within human tissues. Topical clinical investigations have generally reported favourable tolerability. Researchers continue evaluating long-term administration, systemic exposure, copper homeostasis, immunogenicity and route-specific pharmacology. Additional clinical studies are required to establish comprehensive safety profiles for non-topical applications. RESEARCH LIMITATIONS Several important limitations remain: • Predominance of laboratory research • Limited systemic human studies • Variable cosmetic formulations • Incomplete pharmacokinetic characterisation • Differences between topical and systemic administration Consequently, interpretation of current findings should consider both the strength of laboratory evidence and the relative scarcity of large clinical trials.

Current scientific priorities include: • Regenerative medicine • Tissue engineering • Chronic wound management • Hair biology • Skin ageing • Gene regulation • Precision dermatology Continued research aims to clarify how endogenous signalling peptides influence tissue maintenance throughout ageing.